亨迪药业
(301211)
| 流通市值：13.69亿 | | | 总市值：54.75亿 |
| 流通股本：7200.00万 | | | 总股本：2.88亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 520,745,020.94 | 1,022,661,699.57 | 1,663,102,024.22 | 1,694,326,514.68 |
| 应收票据及应收账款 | 70,402,385.55 | 76,525,420.12 | 84,992,222.6 | 67,974,778.58 |
| 其中：应收票据 | 5,123,748.22 | 5,738,353.36 | 14,672,800.43 | 15,529,961.16 |
| 应收账款 | 65,278,637.33 | 70,787,066.76 | 70,319,422.17 | 52,444,817.42 |
| 应收款项融资 | 2,691,154.3 | 2,975,294.74 | 8,217,304 | 7,102,238.49 |
| 预付款项 | 13,238,346.49 | 8,302,060.91 | 8,229,510.9 | 12,262,125.51 |
| 其他应收款合计 | 8,698,567.85 | 4,367,643.54 | 5,233,381.77 | 4,478,312.08 |
| 存货 | 155,087,639.39 | 180,162,422.14 | 167,614,148.3 | 173,804,685.14 |
| 其他流动资产 | 9,159,914.94 | 7,966,289.25 | 6,018,232.61 | 9,600,698.73 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,876,829,237.79 | 1,901,026,904.25 | 2,062,714,828.89 | 2,098,949,170.23 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | - | - |
| 固定资产 | 119,428,946.71 | 123,476,847.87 | 124,027,390.86 | 127,595,996.76 |
| 在建工程 | 350,785,656.54 | 312,049,463.29 | 268,213,677.7 | 228,767,843.16 |
| 使用权资产 | 4,587,185.79 | 4,933,947.27 | 5,280,140.75 | 5,627,470.23 |
| 无形资产 | 69,458,187.73 | 70,020,711.16 | 70,577,101.92 | 71,071,135.94 |
| 长期待摊费用 | 1,118,965.57 | 1,190,388.91 | 1,261,812.25 | 1,333,235.59 |
| 递延所得税资产 | 2,194,552.13 | 2,194,552.13 | 2,194,552.13 | 2,194,552.13 |
| 其他非流动资产 | 2,666,363.57 | 3,926,637.42 | 7,994,759.13 | 11,031,571.75 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 560,239,858.04 | 527,792,548.05 | 479,549,434.74 | 447,621,805.56 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,437,069,095.83 | 2,428,819,452.3 | 2,542,264,263.63 | 2,546,570,975.79 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 88,954,043.01 | 85,195,864.6 | 91,731,980.19 | 117,705,826.1 |
| 其中：应付票据 | - | - | 7,900,000 | 7,900,000 |
| 应付账款 | 88,954,043.01 | 85,195,864.6 | 83,831,980.19 | 109,805,826.1 |
| 合同负债 | 15,592,445.27 | 9,862,540.52 | 10,423,080.89 | 15,005,907.81 |
| 应付职工薪酬 | 10,064,402.26 | 8,481,020.16 | 7,242,397.28 | 10,872,019.72 |
| 应交税费 | 5,694,402.2 | 13,339,907.19 | 9,755,777.54 | 15,918,206.37 |
| 其他应付款合计 | 1,839,441.19 | 3,250,794.32 | 3,996,538.77 | 3,026,094.76 |
| 一年内到期的非流动负债 | 1,508,198.7 | 1,508,198.7 | 1,508,198.7 | 1,508,198.7 |
| 其他流动负债 | 4,708,468.22 | 5,322,553.36 | 8,682,421.35 | 11,105,102.09 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 128,361,400.85 | 126,960,878.85 | 133,340,394.72 | 175,141,355.55 |
| 非流动负债: | | | | |
| 租赁负债 | 3,716,346.68 | 4,063,720.56 | 4,407,294.29 | 5,154,973.12 |
| 递延收益 | 2,070,403.02 | 2,079,516.24 | 2,088,629.46 | 2,097,742.68 |
| 递延所得税负债 | 7,492,063.02 | 7,492,063.02 | 7,492,063.02 | 7,492,063.02 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 13,278,812.72 | 13,635,299.82 | 13,987,986.77 | 14,744,778.82 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 141,640,213.57 | 140,596,178.67 | 147,328,381.49 | 189,886,134.37 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 288,000,000 | 288,000,000 | 288,000,000 | 288,000,000 |
| 资本公积 | 1,756,512,267.22 | 1,756,512,267.22 | 1,756,512,267.22 | 1,756,512,267.22 |
| 专项储备 | 2,322,494.56 | 1,282,420.9 | 869,443.52 | - |
| 盈余公积 | 49,972,124.59 | 49,972,124.59 | 49,972,124.59 | 49,972,124.59 |
| 未分配利润 | 198,621,995.89 | 192,456,460.92 | 299,582,046.81 | 262,200,449.61 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,295,428,882.26 | 2,288,223,273.63 | 2,394,935,882.14 | 2,356,684,841.42 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,295,428,882.26 | 2,288,223,273.63 | 2,394,935,882.14 | 2,356,684,841.42 |
| 负债和股东权益合计 | 2,437,069,095.83 | 2,428,819,452.3 | 2,542,264,263.63 | 2,546,570,975.79 |
| 公告日期 | 2024-10-28 | 2024-08-29 | 2024-04-29 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |